Blog
RSS FeedPosted by Michael Wonder on 21 Nov 2022
New Quality Innovation Expert Group supports medicine innovation
21 November 2022 - The EMA has established a Quality Innovation Expert Group to support innovative approaches for the development, ...
Posted by Michael Wonder on 23 Aug 2022
The EU HTA regulation: a new frontier for access to innovative technologies
23 August 2022 - A new health technology regulation is due to be applied to help EU countries determine the effectiveness ...
Posted by Michael Wonder on 03 Mar 2022
PRIME enables earlier availability of life-changing medicines
3 March 2022 - EMA’s PRIority Medicines (PRIME) scheme has had a positive impact on the authorisation of new medicines that ...
Posted by Michael Wonder on 06 Dec 2018
Why regulators must move with the science if we’re to get innovative new treatments to patients more quickly
5 December 2018 - Professor Paul Workman, discusses the findings of the ICR's new drug access report, which asks how we ...
Posted by Michael Wonder on 20 Oct 2017
New action plan to foster development of advanced therapies
20 October 2017 - Actions address specific challenges identified by stakeholders. ...
Posted by Michael Wonder on 31 May 2017
New action plan to support SMEs as drivers of pharmaceutical innovation
31 May 2017 - 16 actions identified for implementation in 2017-2020. ...
Posted by Michael Wonder on 27 May 2017
Drug approvals bounce back as R&D labs churn out new winners
25 May 2017 - The number of new drugs approved for sale in United States and Europe has bounced back ...
Posted by Michael Wonder on 03 Jun 2016
Regulation of advanced therapy medicines
3 June 2016 - Report details concrete proposals to encourage development and authorisation of advanced therapy medicinal products (ATMPs) in the ...
Posted by Michael Wonder on 11 May 2016
Supporting innovative SMEs as major drivers of new pharmaceutical developments
12 May 2016 - EMA publishes report on the first ten years of its SME initiative. ...
Posted by Michael Wonder on 09 Mar 2016
European scheme to develop drugs for diseases with no treatment launched
8 March 2016 - Unlike the UK’s Early Access to Medicines scheme, PRIME does not shorten the authorisation procedure. ...
Posted by Michael Wonder on 09 Dec 2015
“EMA ready to address challenges ahead”
9 December 2015 - Support to innovative medicines, transparency and patient involvement will be among the priorities of new EMA Executive ...